Stay updated with breaking news from Sumit Chanda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.
The multidisciplinary center will focus on the development of antiviral drugs to combat coronaviruses and other viruses with pandemic potential.
A major new antiviral drug development center led by Scripps Research in La Jolla to prime for the next pandemic is getting a $67 million award over three years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, with potential renewal for two additional years.
The La Jolla institute's partners will include its drug development init Calibr, and UC San Diego
The La Jolla institute's partners will include its drug development init Calibr, and UC San Diego